Article Text

Download PDFPDF
Clinical pharmacology
Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Speaker’s and consulting fees from AstraZeneca, Bayer and Sanofi-Aventis.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Author note References that include an asterisk (*) are considered to be key references.